Updated:
Novo Nordisk Foundation
The Novo Nordisk Foundation is an independent Danish enterprise foundation and non-profit organization. It supports philanthropic purposes with funds from its...
Novo Nordisk Foundation
The Novo Nordisk Foundation is an independent Danish enterprise foundation and non-profit organization. It supports philanthropic purposes with funds from its ownership and investments in companies and other financial assets. It improves people's health and the sustainability of society and the planet through grant giving, partnerships, and long-term investments.
General information
Firm type
Endowment / Foundation
Year founded
1924
Location
Region
Europe
Country
Denmark
City
Hellerup
Corporate office
Tuborg Havnevej 19, 2900 Hellerup, Denmark
Principals
Lars Rebien Sørensen
Chairman
Kasim Kutay
CEO of Novo Holdings A/S
Sector focus
Frequently asked questions
Who runs investment decisions at Novo Nordisk Foundation?
Kasim Kutay serves as CEO of Novo Holdings A/S, the dedicated investment arm. Lars Rebien Sørensen chairs the foundation board. Investment choices integrate direct ownership stakes with grant allocation.
Does Novo Nordisk Foundation participate in fund commitments or only direct deals?
The foundation executes direct ownership in operating companies such as Catalent and Novo Nordisk A/S. It also holds minority positions through Novo Holdings A/S. Public equity filings show additional listed holdings.
What investment stages does Novo Nordisk Foundation typically target?
Holdings span mature operating businesses and select startups. Positions include full ownership of Xellia Pharmaceuticals and early exposure via Biomason and 21st.BIO. The BioInnovation Institute supports life science company formation.
Where does the underlying wealth come from?
Wealth traces to August Krogh and the pharmaceutical operations that became Novo Nordisk A/S. The foundation holds 28.1 percent of Novo Nordisk A/S through Novo Holdings A/S. Returns from that stake and other assets fund operations.
Does Novo Nordisk Foundation maintain philanthropic structures, and how are they separated?
The foundation operates grant programs alongside the BioInnovation Institute and World Diabetes Foundation. These vehicles receive dedicated funding from investment returns. Governance separates commercial ownership from grant decisions.
What is Novo Nordisk Foundation's known posture on co-investments alongside external GPs?
The foundation has partnered with the Bill & Melinda Gates Foundation and Open Philanthropy on the Pandemic Antiviral Discovery initiative. It also collaborates with Wellcome Trust on climate and health projects. Co-funding occurs through named initiatives rather than standard fund vehicles.
How is Novo Nordisk Foundation related to Novo Holdings A/S?
Novo Holdings A/S functions as the investment and ownership arm of the foundation. It holds the 28.1 percent stake in Novo Nordisk A/S and other companies. The foundation board oversees the overall mandate while Novo Holdings executes transactions.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on endowments & foundations?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: